| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.029 | 0.6 |